tiprankstipranks
Trending News
More News >
Eli Lilly and Company Canadian Depositary Receipt (TSE:LLY)
TSX:LLY
US Market

Eli Lilly and Company Canadian Depositary Receipt (LLY) Stock News & Sentiment

Compare
3 Followers
Eli Lilly: Consolidating Incretin Leadership and Multitherapy Growth Supports Buy Rating
Premium
Ratings
Eli Lilly: Consolidating Incretin Leadership and Multitherapy Growth Supports Buy Rating
13d ago
Evan Seigerman, an analyst from BMO Capital, maintained the Buy rating on Eli Lilly & Co. The associated price target remains the same with $1,200.00. Evan Seigerman has given his ...Read more
Eli Lilly: Incretin-Driven Above-Peer Growth Justifies Premium Valuation and Supports Overweight Rating
Premium
Ratings
Eli Lilly: Incretin-Driven Above-Peer Growth Justifies Premium Valuation and Supports Overweight Rating
18d ago
Eli Lilly’s Ventyx Acquisition: Expanding Inflammation and Inflammaging Pipeline to Strengthen Long‑Term Growth and Support Buy Rating
Premium
Ratings
Eli Lilly’s Ventyx Acquisition: Expanding Inflammation and Inflammaging Pipeline to Strengthen Long‑Term Growth and Support Buy Rating
18d ago

News Score - Last 7 Days

Positive
TSE:LLY
Sector Average
Media Buzz
This Week3 articles
Weekly Average10.25 articles
News Sentiment
This Week100%
Sector Average75%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is TSE:LLY’s Media Buzz Sentiment?
3 articles about TSE:LLY were published this week. In an average week, 10.25 articles are published.
    What is TSE:LLY’s weekly average amount of articles?
    In an average week, 10.25 articles about TSE:LLY are published.
      What is TSE:LLY’s News Sentiment?
      100% of articles about TSE:LLY were positive this week, compared to its sector average of 75%.
        Healthcare Stocks that are Trending in the News
        Showing the stocks with the most bullish news sentiment over the past week